Novozymes A/S B (NZYMb)

407.7
-1.4(-0.34%)
  • Volume:
    112,710
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    406.9 - 413.8

NZYMb Overview

Prev. Close
409.1
Day's Range
406.9-413.8
Revenue
16.86B
Open
408
52 wk Range
353.2-545.8
EPS
12.35
Volume
112,710
Market Cap
112.65B
Dividend (Yield)
5.50
(1.35%)
Average Vol. (3m)
304,374
P/E Ratio
34.21
Beta
0.39
1-Year Change
-18.21%
Shares Outstanding
276,307,561
Next Earnings Date
Jan 26, 2023
What is your sentiment on Novozymes B?
or
Market is currently closed. Voting is open during market hours.

Novozymes A/S B Company Profile

Novozymes A/S B Company Profile

Industry
Chemicals
Sector
Materials
Employees
6741
Market
Denmark
  • Type:Equity
  • Market:Denmark
  • ISIN:DK0060336014
  • S/N:227256400

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellBuyBuyNeutral
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Sell
SummaryStrong SellStrong SellNeutralStrong BuySell
  • any news on this? should I wait to buy cheaper?
    0
    • can you confirm the data for feb 14 2014? thank you.
      0